Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: cash position

LL: "FYI, that $7.18M was MY extroplation based on the change in cash position from the end of the year ending 5/31/13 through the end of the quarter ending 11/30/13, and then extrapolating that through the end of the most recent quarter. We don't have an official cash report yet as the 10-Q doesn't have to be filed until April 15, or so."

*FWIW, My personal view is that we are quite a bit lower than what LL thinks.

Share
New Message
Please login to post a reply